Chitosan and collagen are natural, biodegradable, and biocompatible polymers that have been explored for their potential use in the treatment of cardiac dysfunction. [4][5][6][7][8][9] Typically, collagen and chitosan, alone or in combination, are crosslinked using exogenous, sometimes toxic, chemical crosslinkers to improve the hydrogel mechanical properties. 4,10,11 However, we have previously shown that chitosan-collagen composites gel because of ionic interactions at physiological temperature and pH to form mechanically stable hydrogels that are appropriate for in vivo application.12 Furthermore, the collagen-chitosan interaction within the gels resembles the collagen-glycosaminoglycan interaction found in vivo in the extracellular matrix. 13 Thus, chitosan-collagen may mediate physiological cell-matrix interactions.The functional success of hydrogel-based cardiac and cell therapies can be improved by modifying biomaterials with bioactive molecules because bioactive molecules (cytokines,
Original Article© 2015 American Heart Association, Inc.Circ Heart Fail is available at http://circheartfailure.ahajournals.org DOI: 10.1161/CIRCHEARTFAILURE.114.001881Background-Hydrogels are being actively investigated for direct delivery of cells or bioactive molecules to the heart after myocardial infarction (MI) to prevent cardiac functional loss. We postulate that immobilization of the prosurvival angiopoietin-1-derived peptide, QHREDGS, to a chitosan-collagen hydrogel could produce a clinically translatable thermoresponsive hydrogel to attenuate post-MI cardiac remodeling. Methods and Results-In a rat MI model, QHREDGS-conjugated hydrogel (QHG213H), control gel, or PBS was injected into the peri-infarct/MI zone. By in vivo tracking and chitosan staining, the hydrogel was demonstrated to remain in situ for 2 weeks and was cleared in ≈3 weeks. By echocardiography and pressure-volume analysis, the QHG213H hydrogel significantly improved cardiac function compared with the controls. Scar thickness and scar area fraction were also significantly improved with QHG213H gel injection compared with the controls. There were significantly more cardiomyocytes, determined by cardiac troponin-T staining, in the MI zone of the QHG213H hydrogel group; and hydrogel injection did not induce a significant inflammatory response as assessed by polymerase chain reaction and an inflammatory cytokine assay. The interaction of cardiomyocytes and cardiac fibroblasts with QHREDGS was found to be mediated by β 1 -integrins. Conclusions-We demonstrated for the first time that the QHG213H peptide-modified hydrogel can be injected in the beating heart where it remains localized for a clinically effective period. Moreover, the QHG213H hydrogel induced significant cardiac functional and morphological improvements after MI relative to the controls. and activates prosurvival pathways. 20 We identified the short sequence QHREDGS as the integrin-binding motif of Ang1, and the QHREDGS peptide was found to support cardiomyocyte attachment and survival simila...